Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Exercise/Conversion of 10,000 TVTX shares, $265.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $265.2K |
| Jun 10, 2026 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| Jun 3, 2026 | ADC Therapeutics SA (ADCT) | Grant/Award | 45,000 | n/a |
| May 21, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,000 | n/a |
| May 19, 2026 | Travere Therapeutics, Inc. (TVTX) | Sale | 3,250 | $141.3K |
| May 13, 2026 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |
| Nov 4, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,000 | $130.6K |
| Jun 5, 2025 | ADC Therapeutics SA (ADCT) | Grant/Award | 40,000 | n/a |
| May 16, 2025 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 6,500 | n/a |
| May 2, 2025 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |